BETTER TESTING, BETTER TREATMENT

Serial Number 88957798
Registration 6943885
700

Registration Progress

Application Filed
Jun 10, 2020
Under Examination
Jun 22, 2021
Approved for Publication
Apr 27, 2021
Published for Opposition
Apr 27, 2021
Registered
Jan 3, 2023

Trademark Image

BETTER TESTING, BETTER TREATMENT

Basic Information

Serial Number
88957798
Registration Number
6943885
Filing Date
June 10, 2020
Registration Date
January 3, 2023
Published for Opposition
April 27, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 3, 2023
Registration
Registered
Classes
042

Rights Holder

Diaceutics plc

99
Address
55-59 Adelaide Street
BELFAST BT28FE
GB

Ownership History

Diaceutics plc

Original Applicant
99
BELFAST GB

Diaceutics plc

Owner at Publication
99
BELFAST GB

Diaceutics plc

Original Registrant
99
BELFAST GB

Legal Representation

Attorney
MARGARET M. POWERS

USPTO Deadlines

Next Deadline
1078 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230103)
Due Date
January 03, 2029
Grace Period Ends
July 03, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description Documents
Jan 3, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 3, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 2, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 1, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 26, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 24, 2022 IUAF S USE AMENDMENT FILED Loading...
Oct 24, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 25, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 24, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 20, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 20, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 22, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 21, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 10, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 20, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 10, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 22, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 27, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 27, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 7, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 22, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 22, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 22, 2021 ALIE A ASSIGNED TO LIE Loading...
Mar 22, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 22, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 22, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 19, 2021 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Mar 19, 2021 GEAP O EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Mar 19, 2021 EPEN O COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY Loading...
Mar 19, 2021 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
Sep 21, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 21, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 21, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 14, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 5, 2020 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jul 7, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 13, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
provision of information and data relating to medical and veterinary research and development; technical data analysis services, namely, data analysis for medicine and pharmaceutical testing, research and development purposes; information, advice and consultancy in relation to all the aforesaid services, namely, providing information in the field of research and development of pharmaceutical preparations; Software as a service (SAAS) services featuring software in relation to data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; Software as a service (SAAS) services featuring software in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Software as a service (SAAS) services featuring software in relation to data management and visualisation, for generating reports, charts and dashboards; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; Platform as a service (PAAS) featuring computer software platforms for use in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management and visualisation for generating reports, charts and dashboards; information, advice and consultancy in relation to all the aforesaid services
First Use Anywhere: Nov 13, 2018
First Use in Commerce: Nov 13, 2018

Classification

International Classes
042